Patents by Inventor Bruno BAILLON

Bruno BAILLON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200270219
    Abstract: The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms. Also provided are compositions comprising the crystalline forms and methods of use of the crystalline forms.
    Type: Application
    Filed: March 20, 2020
    Publication date: August 27, 2020
    Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Patent number: 10662163
    Abstract: The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: May 26, 2020
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Patent number: 10433552
    Abstract: This invention relates to processes for the preparation of antiparasitic isoxazoline compounds enriched in an enantiomer using quinine-based chiral phase transfer catalyst. The invention also relates to novel quinine-based phase transfer catalysts and to a toluene solvent form of the isoxazoline compound of the invention.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: October 8, 2019
    Assignee: MERIAL, INC.
    Inventors: Chunhua Yang, Loic Patrick Le Hir de Fallois, Charles Q. Meng, Alan Long, Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Publication number: 20190133129
    Abstract: This invention relates to processes for the preparation of antiparasitic isoxazoline compounds enriched in an enantiomer using quinine-based chiral phase transfer catalyst. The invention also relates to novel quinine-based phase transfer catalysts and to a toluene solvent form of the isoxazoline compound of the invention.
    Type: Application
    Filed: November 7, 2018
    Publication date: May 9, 2019
    Applicant: MERIAL INC.
    Inventors: Chunhua Yang, Loic Patrick Le Hir de Fallois, Charles Q. Meng, Alan Long, Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Publication number: 20180354917
    Abstract: The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms. Also provided are compositions comprising the crystalline forms and methods of use of the crystalline forms.
    Type: Application
    Filed: April 5, 2018
    Publication date: December 13, 2018
    Applicant: MERIAL INC.
    Inventors: Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Publication number: 20170311601
    Abstract: This invention relates to processes for the preparation of antiparasitic isoxazoline compounds enriched in an enantiomer using quinine-based chiral phase transfer catalyst. The invention also relates to novel quinine-based phase transfer catalysts and to a toluene solvent form of the isoxazoline compound of the invention.
    Type: Application
    Filed: April 5, 2017
    Publication date: November 2, 2017
    Applicant: MERIAL INC.
    Inventors: Chunhua Yang, Loic Patrick Le Hir de Fallois, Charles Q. Meng, Alan Long, Roelof Johannes Gorter de Vries, Bruno Baillon, Sylvaine Lafont, Myriam Gay de Saint Michel, Stephane Kozlovic
  • Patent number: 9388143
    Abstract: Provided herein are various polymorph forms of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: July 12, 2016
    Assignee: SANOFI
    Inventors: Virginie Baulier, Matthieu Fugier, Stephane Kozlovic, Marc-Antoine Perrin, Bruno Baillon, Myriam Comte
  • Publication number: 20150183752
    Abstract: Provided herein are various polymorph forms of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide.
    Type: Application
    Filed: March 12, 2015
    Publication date: July 2, 2015
    Inventors: Virginie BAULIER, Matthieu FUGIER, Stephane KOZLOVIC, Marc-Antoine PERRIN, Bruno BAILLON, Myriam COMTE
  • Publication number: 20110230553
    Abstract: The invention relates to a novel crystallized form of dronedarone base, to its process of preparation and to pharmaceutical compositions containing said novel crystallized form.
    Type: Application
    Filed: February 4, 2011
    Publication date: September 22, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Bruno BAILLON, Myriam COMTE